 |
|||||
|
|||||
|
|||||
|
|||||
|
|||||
The Journal of Neuroscience, January 7, 2004, 24(1):53-62; doi:10.1523/JNEUROSCI.4503-03.2004
Previous Article | Next Article
Cellular/Molecular
Endocannabinoids Mediate Presynaptic Inhibition of Glutamatergic Transmission in Rat Ventral Tegmental Area Dopamine Neurons through Activation of CB1 Receptors
Miriam Melis,1,2 Marco Pistis,1,2 Simona Perra,1,2 Anna Lisa Muntoni,1,3 Giuliano Pillolla,1,2 andGian Luigi Gessa1,2 1Centre of Excellence, Neurobiology of Addiction, and 2B. B. Brodie Department of Neuroscience, University of Cagliari, Monserrato, 09042 Italy, and 3Consiglio Nazionale delle Ricerche Institute of Neuroscience in Pisa, Section of Cagliari, c/o B. B. Brodie Department of Neuroscience, University of Cagliari, Monserrato, 09042 Italy
The endogenous cannabinoid system has been shown to play a crucial role in controlling neuronal excitability and synaptic transmission. In this study we investigated the effects of a cannabinoid receptor (CB-R) agonist WIN 55,212-2 (WIN) on excitatory synaptic transmission in the rat ventral tegmental area (VTA). Whole-cell patch clamp recordings were performed from VTA dopamine (DA) neurons in an in vitro slice preparation. WIN reduced both NMDA and AMPA EPSCs, as well as miniature EPSCs (mEPSCs), and increased the paired-pulse ratio, indicating a presynaptic locus of its action. We also found that WIN-induced effects were dose-dependent and mimicked by the CB1-R agonist HU210. Furthermore, two CB1-R antagonists, AM281 and SR141716A, blocked WIN-induced effects, suggesting that WIN modulates excitatory synaptic transmission via activation of CB1-Rs. Our additional finding that both AM281 and SR141716A per se increased NMDA EPSCs suggests that endogenous cannabinoids, released from depolarized postsynaptic neurons, might act retrogradely on presynaptic CB1-Rs to suppress glutamate release. Hence, we report that a type of synaptic modulation, previously termed depolarization-induced suppression of excitation (DSE), is present also in the VTA as a calcium-dependent phenomenon, blocked by both AM281 and SR141716A, and occluded by WIN. Importantly, DSE was partially blocked by the D2DA antagonist eticlopride and enhanced by the D2DA agonist quinpirole without changing the presynaptic cannabinoid sensitivity. These results indicate that the two pathways work in a cooperative manner to release endocannabinoids in the VTA, where they play a role as retrograde messengers for DSE via CB1-Rs.
Key words: cannabinoid receptor; dopamine; excitatory transmission; midbrain; retrograde signal; vanilloid receptor
Received Oct 3, 2003; revised November 5, 2003; accepted November 7, 2003.
This article has been cited by other articles:
S. Haj-Dahmane and R.-Y. Shen
Endocannabinoids Suppress Excitatory Synaptic Transmission to Dorsal Raphe Serotonin Neurons through the Activation of Presynaptic CB1 Receptors
J. Pharmacol. Exp. Ther., October 1, 2009; 331(1): 186 - 196.
[Abstract] [Full Text] [PDF]
V. A. Mitchell, H. Kawahara, and C. W. Vaughan
Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey
J. Physiol., June 1, 2009; 587(11): 2511 - 2520.
[Abstract] [Full Text] [PDF]
M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe
Endocannabinoid-Mediated Control of Synaptic Transmission
Physiol Rev, January 1, 2009; 89(1): 309 - 380.
[Abstract] [Full Text] [PDF]
M. Melis, G. Pillolla, A. Luchicchi, A. L. Muntoni, S. Yasar, S. R. Goldberg, and M. Pistis
Endogenous Fatty Acid Ethanolamides Suppress Nicotine-Induced Activation of Mesolimbic Dopamine Neurons through Nuclear Receptors
J. Neurosci., December 17, 2008; 28(51): 13985 - 13994.
[Abstract] [Full Text] [PDF]
M. Scherma, L. V. Panlilio, P. Fadda, L. Fattore, I. Gamaleddin, B. Le Foll, Z. Justinova, E. Mikics, J. Haller, J. Medalie, et al.
Inhibition of Anandamide Hydrolysis by Cyclohexyl Carbamic Acid 3'-Carbamoyl-3-yl Ester (URB597) Reverses Abuse-Related Behavioral and Neurochemical Effects of Nicotine in Rats
J. Pharmacol. Exp. Ther., November 1, 2008; 327(2): 482 - 490.
[Abstract] [Full Text] [PDF]
B. K. Lau and C. W. Vaughan
Muscarinic Modulation of Synaptic Transmission via Endocannabinoid Signalling in the Rat Midbrain Periaqueductal Gray
Mol. Pharmacol., November 1, 2008; 74(5): 1392 - 1398.
[Abstract] [Full Text] [PDF]
B. Pan, C. J. Hillard, and Q.-s. Liu
Endocannabinoid Signaling Mediates Cocaine-Induced Inhibitory Synaptic Plasticity in Midbrain Dopamine Neurons
J. Neurosci., February 6, 2008; 28(6): 1385 - 1397.
[Abstract] [Full Text] [PDF]
L. Orozco-Cabal, J. Liu, S. Pollandt, K. Schmidt, P. Shinnick-Gallagher, and J. P. Gallagher
Dopamine and Corticotropin-Releasing Factor Synergistically Alter Basolateral Amygdala-to-Medial Prefrontal Cortex Synaptic Transmission: Functional Switch after Chronic Cocaine Administration
J. Neurosci., January 9, 2008; 28(2): 529 - 542.
[Abstract] [Full Text] [PDF]
F. R. Bambico, N. Katz, G. Debonnel, and G. Gobbi
Cannabinoids Elicit Antidepressant-Like Behavior and Activate Serotonergic Neurons through the Medial Prefrontal Cortex
J. Neurosci., October 24, 2007; 27(43): 11700 - 11711.
[Abstract] [Full Text] [PDF]
T. M. Fong, X.-M. Guan, D. J. Marsh, C.-P. Shen, D. S. Stribling, K. M. Rosko, J. Lao, H. Yu, Y. Feng, J. C. Xiao, et al.
Antiobesity Efficacy of a Novel Cannabinoid-1 Receptor Inverse Agonist, N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide (MK-0364), in Rodents
J. Pharmacol. Exp. Ther., June 1, 2007; 321(3): 1013 - 1022.
[Abstract] [Full Text] [PDF]
H. Huang, C. Acuna-Goycolea, Y. Li, H. M. Cheng, K. Obrietan, and A. N. van den Pol
Cannabinoids Excite Hypothalamic Melanin-Concentrating Hormone But Inhibit Hypocretin/Orexin Neurons: Implications for Cannabinoid Actions on Food Intake and Cognitive Arousal
J. Neurosci., May 2, 2007; 27(18): 4870 - 4881.
[Abstract] [Full Text] [PDF]
A. Straiker and K. Mackie
Metabotropic suppression of excitation in murine autaptic hippocampal neurons
J. Physiol., February 1, 2007; 578(3): 773 - 785.
[Abstract] [Full Text] [PDF]
D. A. Fortin and E. S. Levine
Differential Effects of Endocannabinoids on Glutamatergic and GABAergic Inputs to Layer 5 Pyramidal Neurons
Cereb Cortex, January 1, 2007; 17(1): 163 - 174.
[Abstract] [Full Text] [PDF]
N. Sang and C. Chen
Lipid Signaling and Synaptic Plasticity
Neuroscientist, October 1, 2006; 12(5): 425 - 434.
[Abstract] [PDF]
P. Pacher, S. Batkai, and G. Kunos
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pharmacol. Rev., September 1, 2006; 58(3): 389 - 462.
[Abstract] [Full Text] [PDF]
N. Wettschureck, M. van der Stelt, H. Tsubokawa, H. Krestel, A. Moers, S. Petrosino, G. Schutz, V. Di Marzo, and S. Offermanns
Forebrain-Specific Inactivation of Gq/G11 Family G Proteins Results in Age-Dependent Epilepsy and Impaired Endocannabinoid Formation
Mol. Cell. Biol., August 1, 2006; 26(15): 5888 - 5894.
[Abstract] [Full Text] [PDF]
U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Endocr. Rev., February 1, 2006; 27(1): 73 - 100.
[Abstract] [Full Text] [PDF]
S. Di, C. Boudaba, I. R. Popescu, F.-J. Weng, C. Harris, V. L. Marcheselli, N. G. Bazan, and J. G. Tasker
Activity-dependent release and actions of endocannabinoids in the rat hypothalamic supraoptic nucleus
J. Physiol., December 15, 2005; 569(3): 751 - 760.
[Abstract] [Full Text] [PDF]
A. Straiker and K. Mackie
Depolarization-induced suppression of excitation in murine autaptic hippocampal neurones
J. Physiol., December 1, 2005; 569(2): 501 - 517.
[Abstract] [Full Text] [PDF]
A. C. Kreitzer and R. C. Malenka
Dopamine Modulation of State-Dependent Endocannabinoid Release and Long-Term Depression in the Striatum
J. Neurosci., November 9, 2005; 25(45): 10537 - 10545.
[Abstract] [Full Text] [PDF]
E. D. Nosyreva and K. M. Huber
Developmental Switch in Synaptic Mechanisms of Hippocampal Metabotropic Glutamate Receptor-Dependent Long-Term Depression
J. Neurosci., March 16, 2005; 25(11): 2992 - 3001.
[Abstract] [Full Text] [PDF]
A. C. Riegel and C. R. Lupica
Independent Presynaptic and Postsynaptic Mechanisms Regulate Endocannabinoid Signaling at Multiple Synapses in the Ventral Tegmental Area
J. Neurosci., December 8, 2004; 24(49): 11070 - 11078.
[Abstract] [Full Text] [PDF]
M. Melis, S. Perra, A. L. Muntoni, G. Pillolla, B. Lutz, G. Marsicano, V. Di Marzo, G. L. Gessa, and M. Pistis
Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons
J. Neurosci., November 24, 2004; 24(47): 10707 - 10715.
[Abstract] [Full Text] [PDF]
S. C. Azad, K. Monory, G. Marsicano, B. F. Cravatt, B. Lutz, W. Zieglgansberger, and G. Rammes
Circuitry for Associative Plasticity in the Amygdala Involves Endocannabinoid Signaling
J. Neurosci., November 3, 2004; 24(44): 9953 - 9961.
[Abstract] [Full Text] [PDF]
J. F. Cheer, K. M. Wassum, M. L. A. V. Heien, P. E. M. Phillips, and R. M. Wightman
Cannabinoids Enhance Subsecond Dopamine Release in the Nucleus Accumbens of Awake Rats
J. Neurosci., May 5, 2004; 24(18): 4393 - 4400.
[Abstract] [Full Text] [PDF]
|
|
|
|
 |
|